Portfolio company
CellAegis Devices
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops automated remote ischaemic conditioning devices for patients experiencing heart attacks or undergoing surgical procedures to protect organs from tissue damage.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Miracor Medical SA
This company develops a pressure-controlled intermittent coronary sinus occlusion system to treat patients with impaired cardiac function and heart attacks.
Forcefield Therapeutics
The company develops protein-based therapeutics designed to protect heart function and prevent cell death in patients following a heart attack.
Haermonics
This company develops automated pericardial flushing systems to prevent blood clots and drainage complications for patients recovering from open-heart surgery.
Protembis
This company develops a cerebral protection system to prevent brain injury and stroke for patients undergoing transcatheter aortic valve replacement and other cardiology procedures.
CryoThermic Systems
This company develops non-invasive cooling wraps and packs for emergency medical services and hospitals to manage patient body temperatures during critical care.
Voyage Biomedical
This company develops selective brain cooling devices to reduce damage from strokes and cardiac arrests for healthcare providers and patients.
CardiacBooster
This medical device company develops percutaneous ventricular assist devices for patients suffering from cardiogenic shock or undergoing high-risk coronary procedures.
Ceryx Medical
This company develops bioelectronic medical devices and pacing technology to treat patients with heart failure, hypertension and neurological injuries.
